The ontogeny of insulin-like growth factor-I (IGF-I) embryonic and extra-embryonic tissue concentrations were determined in the developing turkey embryo. At 2-d intervals, starting on Day 6 of incubation, individual tissues (n = 8 for each stage of incubation) were removed, weighed, pulverized, and extracted in 1 M acetic acid for IGF-I determination. Amniotic and allantoic fluid were collected starting on Day 8, serum on Day 12, and analyzed for IGF-I levels. Serum IGF-I levels were the lowest on Days 12 and 28 of incubation (5.9 and 9.5 ng/mL), respectively, and the highest on Day 20 (16.2 ng/mL). Allantoic and amniotic fluid IGF
tissue IGF-I concentrations varied greatly with regard to tissue and stage of development. Brain IGF-I levels were the highest on Day 8 and lowest on Day 26 (423 vs 35 pg/mg protein, respectively). Tissue IGF-I pattern in the heart mirrored that of brain. Liver IGF-I was low (< 40 pg/mg protein) from Day 10 to 20 and undetectable on Days 22 to 28. Muscle IGF-I levels were similar in the final days of development to those observed in early incubation. Bone IGF-I levels were highest in midincubation and lowest on Day 26. Peptide levels in the gastrointestinal tract (GI) tract and gizzard were dissimilar in that IGF-I was elevated in the GI tract in early incubation and declined with advancing incubation, whereas gizzard IGF-I levels peaked in late incubation. It is apparent that tissue synthesis of IGF-I is differentially regulated within a given tissue and stage of incubation during embryogenesis in the turkey embryo.
INTRODUCTION
The insulin-like growth factors (IGF-I and -II) are anabolic peptides that play crucial roles in embryonic and postnatal development, differentiation, and growth (Daughaday and Rotwein, 1989; DePablo et al., 1990) . Insulin-like growth-factor-I is expressed in the posthatch chicken predominantly in the liver under the regulation of growth hormone (GH), whereas other tissues expressing IGF-I appear to be GH-independent (Rosselot et al., 1995) . It has been suggested that the liver is the major source of IGF-I in postnatal blood (Daughday and Rotwein, 1989) . In the developing chick embryo, IGF-I mRNA transcripts have been detected in various tissues in mid-incubation Kikuchi et al., 1991) , but IGF-I expression is not detectable in the liver until very late in incubation (Serrano et al., 1990) ; blood IGF-I is detectable as early as Day 10 of incubation . We have recently reported that in the developing turkey embryo, IGF-I can be detected in the circulation on Day 10 of development, and that levels peak during mid-embryogenesis (McMurtry et al., 1996) ; however, the potential source of circulating IGF-I in the developing turkey embryo is unknown. In addition, embryonic and extra-embryonic tissues differentiate and develop at different stages during the incubation period. For example, in the chick embryo, the size, rate of growth, and function of the yolk sac and chorioallantoic membranes differ greatly (Burley and Vadehra, 1989) . The objectives of this study were to determine the ontogeny of tissue and embryonic fluid IGF-I in the developing turkey embryo.
MATERIALS AND METHODS
Fertile turkey eggs were incubated under standard incubation conditions. From Day 6 through hatching (Day 28) at 2-d intervals, embryos (n = 8 per stage) were removed and weighed. Only those Day 28 embryos that had just hatched (wet) were used in this study. Selected embryo tissues [lung, Gastrocnemius muscle, gizzard, gastrointestinal (GI) tract, tibiotarsal bone, brain, pancreas, kidney, heart, and liver] as well as extraembryonic membranes (chorioallantoic and yolk sac) were dissected, weighed, and stored at -70 C. For IGF-I analysis, tissues were homogenized in 1 M acetic acid as FIGURE 1. Immunoreactive insulin-like growth factor-I (IGF-I) in turkey embryo yolk sac and chorioallantoic membranes during development. Membranes were extracted with 1 M acetic acid and assayed for IGF-I content in triplicate according to previous methods (D 'Ercole et al., 1984; McMurtry et al., 1994) . Values, expressed as picograms per milligram of protein, are the means ± SEM of 8 observations. Within a membrane, columns with no common superscript differ significantly (P < 0.05). Because of the lack of adequate tissue, no observations were made on Day 6 yolk sac membrane or Day 26 chorioallantoic membranes.
previously described (D'Ercole et al., 1984; McMurtry et al., 1994) . Following homogenization, a 100-mL aliquot of the extract was dried under vacuum in polypropylene assay tubes and reconstituted in 100 mL of assay buffer for IGF-I determination. Blood samples were collected starting on Day 12 from the vitelline blood vessels for serum IGF-I determinations as previously described (McMurtry et al., 1996) . Starting on Day 8 of incubation, amniotic and allantoic fluid were collected using a 25-g needle attached to a 1-cc syringe and assayed for IGF-I content. Insulin-like growth factor-I was quantified by RIA using chicken IGF-I as standard (McMurtry et al., 1994) . This RIA has been validated previously for immunoreactive turkey IGF-I (McMurtry et al., 1994; McMurtry et al., 1996) . All serum, allantoic, and amniotic samples were assayed in a single assay to avoid interassay variation. An intra-assay variation for these samples was calculated to be 4.9%. Tissue IGF-I samples had an intra-assay coefficient of variation of 5.1% and interassay variation of 9.3%. The protein content in the extraction liquid was determined using BCA protein assay kits. 1 Tissue hemoglobin was estimated by the method utilized by D' Ercole et al. (1984) , using turkey hemoglobin 2 as standard. Analysis of variance was used to examine changes in plasma, amniotic, and allantoic fluid as well as tissue IGF-I over time. Differences between hormone values were determined using Fishers least significance difference (LSD) option of the Basic Statistics Module of Statistica for Windows. 3 Stated differences were significant at the P < 0.05 level of probability.
RESULTS
Embryo and organ weights are presented in Table 1 . E xcept for the lungs and chorioallantoic membrane, all tissue and organ weights increased with advancing incubation.
Circulating serum IGF-I concentrations were monitored during incubation (Table 2 ). Insulin-like growth factor-I levels peaked on Day 20, with the lowest IGF-I concentrations observed on Days 12 to 14 and 28 of incubation. Insulin-like growth factor-I concentrations in amniotic and allantoic fluid were very similar throughout incubation (Table 2 ). Peptide levels in allantoic fluid remained unchanged during incubation, averaging between 2.21 to 3.63 ng/mL (Table 2) . Amniotic fluid IGF-I levels were unchanged from Days 8 to 20, with a significant elevation in levels noted on Day 22 (Table 2) .
The IGF-I peptide content in tissues was corrected for extracted tissue blood content, and therefore does not represent contamination from IGF present in blood. Tissue IGF-I levels varied greatly between tissues and stage of development. In the extra-embryonic membranes, IGF-I levels were 8-to 10-fold greater in the chorioallantoic membrane (CAM) than in the yolk sac membrane (Figure 1 ). Chorioallantoic membrane IGF-I concentrations peaked on Day 12 of incubation, and remained elevated for the duration of incubation. Yolk sac membrane IGF-I content gradually increased from a low of 0.86 pg/mg protein to levels averaging greater than 20 pg/mg protein on Day 16 of incubation. Peptide levels remained essentially unchanged for the remainder of development.
Brain IGF-I peptide levels were at their greatest in early development (Day 8, 423 pg/mg protein), and gradually declined for the remainder of incubation (Figure 2) . A similar pattern was evident in developing bone, with IGF-I levels being the greatest (>100 pg/mg protein) on Days 10 to 14, and decreasing to concentrations less than 50 pg/mg protein just prior to hatching (Figure 2) .
Determination of peptide content in the lung and pancreas was limited to the later stages of incubation because of organ size. Insulin-like growth factor-I content exceeded 100 pg/mg protein in both tissues, and declined in the final 6 d of development to concentrations averaging less than 50 pg/mg protein ( 
FIGURE 2. Immunoreactive insulin-like growth factor-I (IGF-I) in turkey embryo brain and bone (tibiotarsal) tissue during development.
Each tissue was extracted with 1 M acetic acid and assayed for IGF-I content in triplicate according to previous methods (D 'Ercole et al., 1984; McMurtry et al., 1994) . Values, expressed as picograms per milligram of protein, are the means ± SEM of 8 observations. Within a tissue, columns with no common superscript differ significantly (P < 0.05). Insufficient bone tissue was available for extraction on Days 6 and 8. 'Ercole et al., 1984; McMurtry et al., 1994) . Values, expressed as picograms per milligram of protein, are the means ± SEM of 8 observations. Within a tissue, columns with no common superscript differ significantly (P < 0.05).
Compared to the other tissues surveyed, IGF peptide concentrations in skeletal muscle were similar in the final days of development (Days 18 to 20 and 24 to 28) to that observed in early incubation (Days 6 and 8) ( Figure 5 ). Conversely, heart muscle peptide levels were the greatest on Day 8, declined to levels less than 50 pg/ mg protein on Day 14 through 24, and less than 25 pg on Days 26 and 28 ( Figure 5 ).
In the kidney, IGF peptide levels fluctuated from Day 16 to 24, and declined to the lowest concentrations at hatching (Figure 6 
DISCUSSION
We have investigated the ontogeny of embryonic and extra-embryonic tissue IGF-I levels in the developing turkey embryo. In this study, because the tissue IGF-I concentration has been corrected for blood contamination, we have made the assumption that assayable tissue IGF-I represents local peptide synthesis.
Insulin-like growth factor-I was detectable in serum on Day 12 of incubation, the earliest time point in this study. It was previously reported that IGF-I can be detected on Day 10 of incubation in the turkey embryo (McMurtry et al., 1996) . Similar to what was previously noted (McMurtry et al., 1996) , a mid-incubation peak in circulating IGF-I was observed in this study. Much the same has been observed to occur in the developing chick embryo (Kikuchi et al., 1991; Robcis et al., 1991) . The importance of the mid-incubation elevation in circulating IGF-I in these two avian species is unknown. Furthermore, the source of blood IGF-I is speculative in light of the observations that IGF-I mRNA is not expressed in the liver until very late in incubation in the chick embryo (Serrano et al., 1990; Kikuchi et al., 1991; Tanaka et al., 1996) . In our study, very small concentrations of IGF-peptide were detected in liver in early development (Days 10 to 20), whereas no IGF could be detected from Days 22 to hatching. This result is in disagreement with previous studies in which no IGF-I mRNA expression was measurable in chick embryo liver until late in incubation (Kikuchi et al., 1991; Tanaka et al., 1996) . Observations reported in this study suggest that IGF-I mRNA is expressed in the liver in early embryonic 'Ercole et al., 1984; McMurtry et al., 1994) . Values, expressed as picograms per milligram of protein, are the means ± SEM of 8 observations. Within a tissue, columns with no common superscript differ significantly (P < 0.05). No gizzard tissue was collected on Days 10 to 14.
FIGURE 5. Immunoreactive insulin-like growth factor-I (IGF-I) in turkey embryo skeletal (Gastrocnemius) and cardiac muscle during development. Each tissue was extracted with 1 M acetic acid and assayed for IGF-I content in triplicate according to previous methods (D 'Ercole et al., 1984; McMurtry et al., 1994) . Values, expressed as picograms per milligram of protein, are the means ± SEM of 8 observations. Within a tissue, columns with no common superscript differ significantly (P < 0.05). No heart tissue was collected on Day 6. FIGURE 6. Immunoreactive insulin-like growth factor-I (IGF-I) in turkey embryo liver and kidney tissue during development. Liver was extracted with 1 M acetic acid and assayed for IGF-I content in triplicate according to previous methods (D 'Ercole et al., 1984; McMurtry et al., 1994) . Values, expressed as picograms per milligram of protein, are the means ± SEM of 8 observations. Within a tissue, columns with no common superscript differ significantly (P > 0.05). No kidney tissue was analyzed prior to Day 16. * denotes that IGF-I levels were undetectable (< 9 pg per tube).
development. Postnatally, the liver is considered to be the major source of blood IGF-I production (Daughaday and Rotwein, 1989) . Therefore, it can be hypothesized that during embryonic development in the avian species, the origin of a majority of circulating IGF-I must be of extra-hepatic tissue origin. Although tissue IGF-I mRNA expression has not been reported for the turkey, it is highly probable that a similar situation exists for turkey and chick embryos.
In the chick embryo, it is suggested that IGF-I is involved in many aspects of embryo development, including, but not limited to, the growth of the embryo (Girbau et al., 1987) ; differentiation of myoblasts (Schmid et al., 1983) , eye lens fiber cells (Beebe et al., 1987) , and retina (Calvaruso et al., 1996) , and limb bud outgrowth (Dealy and Kosher, 1996) . Sun et al., (1992) have shown that IGF-I is important to turkey embryo myoblast differentiation. The mechanisms by which the IGF influence embryonic development are not fully understood. Most likely these peptides involve a dynamic interplay of autocrine-paracrine-endocrine effects during development. One of the more important functions of the IGF are their potential to act in a paracrine or autocrine function (D'Ercole et al., 1984; Holly and Wass, 1989) . McGuinness and Cogburn (1991) have suggested that the growth-promoting actions of IGF-I are mainly coordinated by autocrine-paracrine mechanisms in birds. We are aware of only one other study in which tissue IGF-I levels were monitored throughout incubation (Calvaruso et al., 1996) . Insulin-like growth factor-I concentrations in the chick embryo retina increased with advancing development. Our data indicate that IGF-I is synthesized in many embryonic tissues (as well as extraembryonic) during incubation. It is evident that the IGF-I peptide concentrations vary depending on stage of development and tissue. In general, peptide levels were found to be greatest in early to mid-incubation, and lowest at hatching. For example, brain IGF-I concentrations were the greatest early in development (> 400 pg/ mg protein) and declined with advancing incubation. Previously, others have reported that IGF-I mRNA activity is detectable on Day 16 (Tanaka et al., 1996) and Day 17 (Kikuchi et al., 1991) of chick embryo development. In neither of these studies was tissue IGF-I peptide content measured in conjunction with mRNA activity.
Skeletal muscle is a major target tissue for the IGF, stimulating proliferation and differentiation of turkey embryonic myoblasts and satellite cells (McFarland et al., 1991) . In this study, IGF-I was detectable as early as Day 6 of incubation, with IGF levels being fairly constant throughout incubation. Insulin-like growth factor-I mRNA expression was detected in chick embryo muscle on Day 16 (Tanaka et al., 1996) and 17 (Kikuchi et al., 1991) of incubation.
Our results suggest that IGF-I is produced in cardiac tissue throughout development in the turkey embryo. Whether IGF-I is produced locally in the heart is unresolved, as Tanaka et al. (1996) reported IGF-I mRNA expression in chick embryo heart muscle, although others (Kikuchi et al., 1991) could not confirm this observation.
Factor(s) regulating IGF-I synthesis in the turkey embryo are unknown. In postnatal and growing mammals, the fact that IGF synthesis is closely linked to GH is well-documented (Mathews et al., 1986; Daughaday and Rotwein, 1989 ; however, in the developing embryo this relationship is clearly not evident. Growth hormone is undetectable in the circulation until very late incubation in the chick embryo (Harvey et al., 1979) or turkey embryo (McMurtry et al., 1990) . Furthermore, GHproducing somatotrophs are not evident in the chick embryo pituitary until Day 16 of incubation (Porter et al., 1995) . Therefore, yet to be determined factor(s) other than GH regulate IGF synthesis in the developing avian embryo. In addition, the complexity of IGF-I gene regulation in chickens is further confounded by the observation that lack of parallelism exists between changes in IGF-I peptide and IGF-I mRNA levels (Rosselot et al., 1995) . This finding suggests that when evaluating tissue IGF-I status in birds, IGF peptide concentrations may more accurately reflect peptide activity than mRNA activity alone.
In summary, IGF-I concentrations in various tissues of the developing turkey embryo have been determined. All extra-embryonic and embryonic tissues sampled (except for the liver) had measurable IGF-I at all intervals sampled. Changes in tissue IGF-I levels are not reflected in circulating IGF concentrations. It is apparent that tissue synthesis of IGF-I is differentially regulated within a given tissue and stage of incubation during embryogenesis in the turkey embryo. That tissue IGF-I is detectable in all stages of development suggests that IGF-I gene expression occurs very early in embryonic development, and that IGF-I has a significant role in turkey embryo development.
